Transaction · 0001610717-26-000164

Saxonov Serge

Saxonov Serge, CEO, reported an open-market or private sale at 10x Genomics, Inc. involving 10718.000000 shares for an estimated $264833.21. Reported holdings after the transaction were 1138380.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCEO
TXG10x Genomics, Inc.
Filing timeMay 27
Trade dateMay 26, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$25.51
Pre-filing
1mo ago -13.4%1w ago -12.6%1d ago -7.2%
Returns since
7d +26.0%30d +44.1%90d +160.1%180d +160.1%1y +160.1%

TXG price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
TXG since 2026-05-27Filed 100 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001610717-26-000164
Class A Common Stock
Transaction date
May 26, 2026
Filed May 27, 2026, 09:57 PM · 1d delay
Shares
10.7k sh
$2.47k per share
Estimated value
-$26.4M
Computed from shares × price
Holdings after
1.13M sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Repeat Seller 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Executive Officer

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

  2. F2

    The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on November 29, 2025.

  3. F3

    This transaction was executed in multiple trades at prices ranging from $24.45 to $24.88, inclusive. The price reported above reflects the weighted average sale price. The Reporting Person undertakes…

  4. F4

    The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.

  5. F5

    The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.

  6. F6

    The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.

Original filing · 0001610717-26-000164
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

TXG